Additionally, the compound alanolactone inhibits interleukin-6 (IL-6)-induced STAT3 phosphorylation, down-regulates the expression of SOX2, OCT4, NANOG, CD133, and CD44, and up-regulates P53 expression, modulating the stemness of PCa cells.139. Here, IL6 is linked to posterior cortical atrophy.